Comparative assessment of von Willebrand factor multimers vs activity for von Willebrand disease using modern contemporary methodologies. Issue 3 (11th March 2020)

• Record Type: Journal Article
• Authors: Favaloro, Emmanuel J.; Oliver, Susan; Mohammed, Soma; Vong, Ronny
• Is Part Of: Haemophilia. Volume 26:Issue 3(2020)
• Page Start: 503
• Page End: 512
• Publication Date: 2020-03-11
• Subjects: von Willebrand disease -- von Willebrand factor -- VWF activity -- VWF multimers; Hemophilia -- Periodicals; 616.1572005
• DOI: 10.1111/hae.13957
• Languages: English
• ISSNs: 1351-8216

Abstract

Abstract: Introduction: Diagnosis of von Willebrand disease (VWD) is challenging due to heterogeneity of VWD and test limitations. Many von Willebrand factor (VWF) assays are utilized, including antigen (Ag), activity and multimer analysis. Activity assays include ristocetin cofactor using platelets (VWF:RCo) or other particles incorporating recombinant glycoprotein I ('VWF:GPIbR'), or other GPI binding assays using gain‐of‐function mutations ('VWF:GPIbM'), or collagen binding (VWF:CB). Aim: To comparatively evaluate modern contemporary VWF activity assays vs VWF multimer analysis using modern contemporary methods. Materials and methods: Several VWF activity assays (VWF:RCo, VWF:GPIbR, VWF:GPIbM, VWF:CB) assessed (typically as a ratio against VWF:Ag) against a new semi‐automated procedure for different types of VWD (1, 3, 2A, 2B, 2M), plus control material (n = 580). The evaluation also focussed on relative loss of high and very high molecular weight multimers (HMWM and VHMWM) by densitometric scanning. Results: All evaluated VWF activity/Ag ratios showed high correlation to the presence/absence of HMWM and VHMWM, although VWF:CB/Ag and VWF:GPIbR/Ag ratios using an automated chemiluminescence method yielded highest correlation coefficients ( r = .909 and .874, respectively, for HMWM). Use of the investigative procedure (VHMWM) identified fewer false positives for 'loss' in type 1 VWD. Conclusions: This comparative investigation identified that new automated chemiluminescence VWF activity assays best identified relative loss or presence of HMWM and VHMWM according to activity to Ag ratios and an alternative investigative method for identifying VHMWM in multimer testing for a new commercial multimer method may lead to fewer false identifications of HMW loss in type 1 VWD.